Clearmind Medicine
(NASDAQ) CMND
Clearmind Medicine Financials at a Glance
Market Cap
$3.48MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$7.90M
EPS (TTM)
-$185.93
P/E Ratio
-0.01
Dividend
$0.00
Beta (Volatility)
0.34 (Low)
Dividend
$0.00
Beta (Volatility)
0.34 (Low)
Price
$2.14
Volume
9,049,804
Open
$2.09
Price
$2.14
Volume
9,049,804
Open
$2.09
Previous Close
$2.12
Daily Range
$2.01 - $2.22
52-Week Range
$2.01 - $524.00
Estimated Earnings Date
Jun 15, 2026
Dividend
$0.00
Beta (Volatility)
0.34 (Low)
Price
$2.14
Volume
9,049,804
Open
$2.09
Previous Close
$2.12
Daily Range
$2.01 - $2.22
52-Week Range
$2.01 - $524.00
Estimated Earnings Date
Jun 15, 2026
CMND News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Clearmind Medicine
Industry
Pharmaceuticals
Sector
Health CareCEO
Adi Zuloff-Shani, PhD
Website
www.clearmindmedicine.comHeadquarters
Vancouver, BC V6H 1A5, CA
CMND Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-138.23%
Return on Capital
-190.72%
Return on Assets
-54.40%
Earnings Yield
-100.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.48MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
1.49M
Volume
9.05M
Avg. Volume
2.21M
Financials (TTM)
Gross Profit
-$52.58K
Operating Income
-$8.09M
EBITDA
-$7.34M
Operating Cash Flow
-$6.76M
Capital Expenditure
$0.00
Free Cash Flow
-$6.76M
Cash & ST Invst.
$13.59M
Total Debt
$85.59K
Clearmind Medicine Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$13.90K
-16.1%
Gross Margin
0.00%
N/A
Market Cap
$3.48MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$869.05K
N/A
Employees
4
N/A
Net Income
-$2.05M
-161.0%
EBITDA
-$1.56M
-109.3%
Quarterly Fundamentals
Total Cash
$13.59M
+111.6%
Total Debt
$85.59K
+72.2%
Accounts Receivable
$551.69K
+120.2%
Inventory
$0.00
N/A
Long Term Debt
$44.35K
N/A
Short Term Debt
$41.24K
-17.0%
Return on Assets
-54.40%
N/A
Return on Invested Capital
-70.16%
N/A
Free Cash Flow
-$1.79M
-18.1%
Operating Cash Flow
-$1.79M
-18.1%